{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:42:55Z","timestamp":1791474175508,"version":"4.3.4"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"13","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The generation of protective CD8 T-cell memory against tumor-expressed self-antigens is an important but elusive goal of cancer immunotherapy. The possibility that a progressive, poorly immunogenic tumor can induce T-cell memory against self-antigens has not previously been studied. Herein, we report that growth of the poorly immunogenic B16 melanoma in the absence of regulatory T cells (Treg) generates CD8 T-cell responses that develop into functional memory after the tumor has been surgically excised. Tumor-primed memory T cells recognized melanocyte differentiation antigens TRP-2\/DCT and gp100 and persisted for as long as 5 months following surgical tumor excision. Phenotypic analysis showed that these cells develop into both central and effector memory T-cell subsets, which produce IFN-\u03b3 and interleukin-2 on reencounter with antigen. Most importantly, tumor-primed memory T cells mediated the rejection of intradermal and systemically disseminated challenge tumors given 30 to 60 days following surgery. Tumor-excised mice also developed autoimmune vitiligo, showing that Treg cells prevent tissue-specific autoimmunity in tumor-bearing hosts. This study establishes that Treg depletion in tumor-bearing hosts drives the natural development of protective T-cell memory. Generating such responses may aid in the clinical management of tumor recurrence and metastasis following surgery. [Cancer Res 2007;67(13):6468\u201376]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1264","type":"journal-article","created":{"date-parts":[[2007,7,6]],"date-time":"2007-07-06T18:51:05Z","timestamp":1183747865000},"page":"6468-6476","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Induction of Postsurgical Tumor Immunity and T-Cell Memory by a Poorly Immunogenic Tumor"],"prefix":"10.1158","volume":"67","author":[{"given":"Peisheng","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology and the Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik L.","family":"Co\u0302te\u0301","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and the Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor C.","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and the Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Usherwood","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and the Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Turk","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology and the Norris Cotton Cancer Center, Dartmouth Medical School, Lebanon, New Hampshire"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,7,6]]},"reference":[{"key":"2022061623333464600_B1","unstructured":"Prehn RT, Main JM. Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst\u20081957; 18: 769\u201378."},{"key":"2022061623333464600_B2","doi-asserted-by":"crossref","unstructured":"Bursuker I, North RJ. Immunological consequences of tumor excision: from active immunity to immunological memory. Int J Cancer\u20081986; 37: 275\u201381.","DOI":"10.1002\/ijc.2910370216"},{"key":"2022061623333464600_B3","doi-asserted-by":"crossref","unstructured":"Klebanoff CA, Gattinoni L, Restifo NP. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev\u20082006; 211: 214\u201324.","DOI":"10.1111\/j.0105-2896.2006.00391.x"},{"key":"2022061623333464600_B4","doi-asserted-by":"crossref","unstructured":"Turk MJ, Guevara-Patino JA, Rizzuto GA, Engelhorn ME, Houghton AN. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med\u20082004; 200: 771\u201382.","DOI":"10.1084\/jem.20041130"},{"key":"2022061623333464600_B5","doi-asserted-by":"crossref","unstructured":"Romero P, Rod Dunbar P, Valmori D, et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med\u20081998; 188: 1641\u201350.","DOI":"10.1084\/jem.188.9.1641"},{"key":"2022061623333464600_B6","unstructured":"Valmori D, Scheibenbogen C, Dutoit V, et al. Circulating tumor-reactive CD8+ T cells in melanoma patients contain a CD45RA+CCR7\u2212 effector subset exerting ex vivo tumor-specific cytolytic activity. Cancer Res\u20082002; 62: 1743\u201350."},{"key":"2022061623333464600_B7","doi-asserted-by":"crossref","unstructured":"Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol\u20082006; 6: 295\u2013307.","DOI":"10.1038\/nri1806"},{"key":"2022061623333464600_B8","doi-asserted-by":"crossref","unstructured":"Kursar M, Bonhagen K, Fensterle J, et al. Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses. J Exp Med\u20082002; 196: 1585\u201392.","DOI":"10.1084\/jem.20011347"},{"key":"2022061623333464600_B9","doi-asserted-by":"crossref","unstructured":"Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med\u20082003; 198: 889\u2013901.","DOI":"10.1084\/jem.20030171"},{"key":"2022061623333464600_B10","doi-asserted-by":"crossref","unstructured":"Mullins DW, Sheasley SL, Ream RM, Bullock TN, Fu YX, Engelhard VH. Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and effector T cells in lymphoid tissues and determines the pattern of regional tumor control. J Exp Med\u20082003; 198: 1023\u201334.","DOI":"10.1084\/jem.20021348"},{"key":"2022061623333464600_B11","doi-asserted-by":"crossref","unstructured":"Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol\u20082003; 171: 5940\u20137.","DOI":"10.4049\/jimmunol.171.11.5940"},{"key":"2022061623333464600_B12","doi-asserted-by":"crossref","unstructured":"Luo Y, Zhou H, Mizutani M, et al. A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence. Cancer Res\u20082005; 65: 3419\u201327.","DOI":"10.1158\/0008-5472.CAN-04-3120"},{"key":"2022061623333464600_B13","doi-asserted-by":"crossref","unstructured":"Overwijk WW, Theoret MR, Finkelstein SE, et al. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med\u20082003; 198: 569\u201380.","DOI":"10.1084\/jem.20030590"},{"key":"2022061623333464600_B14","unstructured":"Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C. Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res\u20082001; 61: 1095\u20139."},{"key":"2022061623333464600_B15","doi-asserted-by":"crossref","unstructured":"Bloom MB, Perry-Lalley D, Robbins PF, et al. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med\u20081997; 185: 453\u20139.","DOI":"10.1084\/jem.185.3.453"},{"key":"2022061623333464600_B16","doi-asserted-by":"crossref","unstructured":"Overwijk WW, Tsung A, Irvine KR, et al. gp100\/pmel 17 is a murine tumor rejection antigen: induction of \u201cself\u201d-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J Exp Med\u20081998; 188: 277\u201386.","DOI":"10.1084\/jem.188.2.277"},{"key":"2022061623333464600_B17","doi-asserted-by":"crossref","unstructured":"Kohm AP, McMahon JS, Podojil JR, et al. Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol\u20082006; 176: 3301\u20135.","DOI":"10.4049\/jimmunol.176.6.3301"},{"key":"2022061623333464600_B18","doi-asserted-by":"crossref","unstructured":"Kemp RA, Powell TJ, Dwyer DW, Dutton RW. Cutting edge: regulation of CD8+ T cell effector population size. J Immunol\u20082004; 173: 2923\u20137.","DOI":"10.4049\/jimmunol.173.5.2923"},{"key":"2022061623333464600_B19","doi-asserted-by":"crossref","unstructured":"Hataye J, Moon J, Khoruts A, Reilly C, Jenkins M. Naive and memory CD4+ T cell survival controlled by clonal abundance. Science\u20082006; 312: 114\u20136.","DOI":"10.1126\/science.1124228"},{"key":"2022061623333464600_B20","doi-asserted-by":"crossref","unstructured":"Klebanoff CA, Gattinoni L, Torabi-Parizi P, et al. Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A\u20082005; 102: 9571\u20136.","DOI":"10.1073\/pnas.0503726102"},{"key":"2022061623333464600_B21","doi-asserted-by":"crossref","unstructured":"Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature\u20081999; 401: 708\u201312.","DOI":"10.1038\/44385"},{"key":"2022061623333464600_B22","doi-asserted-by":"crossref","unstructured":"Weninger W, Crowley MA, Manjunath N, von Andrian UH. Migratory properties of naive, effector, and memory CD8+ T cells. J Exp Med\u20082001; 194: 953\u201366.","DOI":"10.1084\/jem.194.7.953"},{"key":"2022061623333464600_B23","doi-asserted-by":"crossref","unstructured":"Wherry EJ, Barber DL, Kaech SM, Blattman JN, Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc Natl Acad Sci U S A\u20082004; 101: 16004\u20139.","DOI":"10.1073\/pnas.0407192101"},{"key":"2022061623333464600_B24","doi-asserted-by":"crossref","unstructured":"Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol\u20082003; 4: 225\u201334.","DOI":"10.1038\/ni889"},{"key":"2022061623333464600_B25","doi-asserted-by":"crossref","unstructured":"Turk MJ, Wolchok JD, Guevara-Patino JA, Goldberg SM, Houghton AN. Multiple pathways to tumor immunity and concomitant autoimmunity. Immunol Rev\u20082002; 188: 122\u201335.","DOI":"10.1034\/j.1600-065X.2002.18811.x"},{"key":"2022061623333464600_B26","doi-asserted-by":"crossref","unstructured":"Bystryn JC, Rigel D, Friedman RJ, Kopf A. Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol\u20081987; 123: 1053\u20135.","DOI":"10.1001\/archderm.123.8.1053"},{"key":"2022061623333464600_B27","doi-asserted-by":"crossref","unstructured":"He H, Wisner P, Yang G, et al. Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model. J Transl Med\u20082006; 4: 24.","DOI":"10.1186\/1479-5876-4-24"},{"key":"2022061623333464600_B28","doi-asserted-by":"crossref","unstructured":"van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med\u20081999; 190: 355\u201366.","DOI":"10.1084\/jem.190.3.355"},{"key":"2022061623333464600_B29","doi-asserted-by":"crossref","unstructured":"Ercolini AM, Ladle BH, Manning EA, et al. Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response. J Exp Med\u20082005; 201: 1591\u2013602.","DOI":"10.1084\/jem.20042167"},{"key":"2022061623333464600_B30","doi-asserted-by":"crossref","unstructured":"Shimizu J, Yamazaki S, Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol\u20081999; 163: 5211\u20138.","DOI":"10.4049\/jimmunol.163.10.5211"},{"key":"2022061623333464600_B31","doi-asserted-by":"crossref","unstructured":"Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med\u20082001; 194: 823\u201332.","DOI":"10.1084\/jem.194.6.823"},{"key":"2022061623333464600_B32","doi-asserted-by":"crossref","unstructured":"Antony PA, Piccirillo CA, Akpinarli A, et al. CD8+ T cell immunity against a tumor\/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol\u20082005; 174: 2591\u2013601.","DOI":"10.4049\/jimmunol.174.5.2591"},{"key":"2022061623333464600_B33","doi-asserted-by":"crossref","unstructured":"Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets. Curr Opin Immunol\u20082005; 17: 326\u201332.","DOI":"10.1016\/j.coi.2005.04.010"},{"key":"2022061623333464600_B34","doi-asserted-by":"crossref","unstructured":"Kaech SM, Hemby S, Kersh E, Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell\u20082002; 111: 837\u201351.","DOI":"10.1016\/S0092-8674(02)01139-X"},{"key":"2022061623333464600_B35","doi-asserted-by":"crossref","unstructured":"Badovinac VP, Porter BB, Harty JT. CD8+ T cell contraction is controlled by early inflammation. Nat Immunol\u20082004; 5: 809\u201317.","DOI":"10.1038\/ni1098"},{"key":"2022061623333464600_B36","doi-asserted-by":"crossref","unstructured":"Roberts AD, Ely KH, Woodland DL. Differential contributions of central and effector memory T cells to recall responses. J Exp Med\u20082005; 202: 123\u201333.","DOI":"10.1084\/jem.20050137"},{"key":"2022061623333464600_B37","doi-asserted-by":"crossref","unstructured":"Obar JJ, Fuse S, Leung EK, Bellfy SC, Usherwood EJ. Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J Virol\u20082006; 80: 8303\u201315.","DOI":"10.1128\/JVI.00237-06"},{"key":"2022061623333464600_B38","doi-asserted-by":"crossref","unstructured":"Tewari K, Sacha J, Gao X, Suresh M. Effect of chronic viral infection on epitope selection, cytokine production, and surface phenotype of CD8 T cells and the role of IFN-\u03b3 receptor in immune regulation. J Immunol\u20082004; 172: 1491\u2013500.","DOI":"10.4049\/jimmunol.172.3.1491"},{"key":"2022061623333464600_B39","doi-asserted-by":"crossref","unstructured":"Dannull J, Su Z, Rizzieri D, et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest\u20082005; 115: 3623\u201333.","DOI":"10.1172\/JCI25947"},{"key":"2022061623333464600_B40","doi-asserted-by":"crossref","unstructured":"Attia P, Maker AV, Haworth LR, Rogers-Freezer L, Rosenberg SA. Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma. J Immunother\u20082005; 28: 582\u201392.","DOI":"10.1097\/01.cji.0000175468.19742.10"},{"key":"2022061623333464600_B41","doi-asserted-by":"crossref","unstructured":"Chace JH, Cowdery JS, Field EH. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naive CD4 cells and spares activated CD4 cells. J Immunol\u20081994; 152: 405\u201312.","DOI":"10.4049\/jimmunol.152.2.405"},{"key":"2022061623333464600_B42","doi-asserted-by":"crossref","unstructured":"Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science\u20082003; 300: 337\u20139.","DOI":"10.1126\/science.1082305"},{"key":"2022061623333464600_B43","doi-asserted-by":"crossref","unstructured":"Janssen EM, Droin NM, Lemmens EE, et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature\u20082005; 434: 88\u201393.","DOI":"10.1038\/nature03337"},{"key":"2022061623333464600_B44","doi-asserted-by":"crossref","unstructured":"Sun JC, Williams MA, Bevan MJ. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol\u20082004; 5: 927\u201333.","DOI":"10.1038\/ni1105"},{"key":"2022061623333464600_B45","doi-asserted-by":"crossref","unstructured":"Bursuker I, North R. Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity. J Exp Med\u20081984; 159: 1312\u201321.","DOI":"10.1084\/jem.159.5.1312"},{"key":"2022061623333464600_B46","doi-asserted-by":"crossref","unstructured":"Salvadori S, Martinelli G, Zier K. Resection of solid tumors reverses T cell defects and restores protective immunity. J Immunol\u20082000; 164: 2214\u201320.","DOI":"10.4049\/jimmunol.164.4.2214"},{"key":"2022061623333464600_B47","doi-asserted-by":"crossref","unstructured":"Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res\u20082004; 64: 2205\u201311.","DOI":"10.1158\/0008-5472.CAN-03-2646"},{"key":"2022061623333464600_B48","doi-asserted-by":"crossref","unstructured":"Ghiringhelli F, Puig PE, Roux S, et al. Tumor cells convert immature myeloid dendritic cells into TGF-\u03b2-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med\u20082005; 202: 919\u201329.","DOI":"10.1084\/jem.20050463"},{"key":"2022061623333464600_B49","doi-asserted-by":"crossref","unstructured":"Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB. Vitiligo in patients with metastatic melanoma: a good prognostic sign. J Am Acad Dermatol\u20081983; 9: 689\u201396.","DOI":"10.1016\/S0190-9622(83)70182-9"},{"key":"2022061623333464600_B50","doi-asserted-by":"crossref","unstructured":"Phan GQ, Yang JC, Sherry RM, et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci U S A\u20082003; 100: 8372\u20137.","DOI":"10.1073\/pnas.1533209100"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/13\/6468\/2570824\/6468.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/13\/6468\/2570824\/6468.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T22:08:19Z","timestamp":1683929299000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/13\/6468\/533247\/Induction-of-Postsurgical-Tumor-Immunity-and-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,1]]},"references-count":50,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2007,7,6]]},"published-print":{"date-parts":[[2007,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1264","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,1]]}}}